36.5.7Bu'CL, ANTI-ALPHA 1,6 DEXTRAN
14.7.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
SC8'CL, ANTI-MCPS
F6H3'CL, ANTI-DEXTRAN B512
A5.B12.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
42.5D4.2'CL, ANTI-ALPHA 1,6 DEXTRAN
SC7'CL, ANTI-MCPS
27.7.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
F4B6'CL, ANTI-DEXTRAN B512
DN2'CL, ANTI-MCPS
SC3'CL, ANTI-MCPS
42.4B.12.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX5, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
58.2C.10.3'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
40-50'CL, ANTI-DIGOXIN
35-20, ANTI-DIGOXIN
27.10.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
27.4b.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
F1A5'CL, ANTI-DEXTRAN B512
mAb5.G3'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE)
3.2.3E5'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
SC11'CL, ANTI-MCPS
42.8E.9.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
J558, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN
2.31.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
17-9'CL, ANTI-DEXTRAN B512
F1C1'CL, ANTI-DEXTRAN B512
42.8G.4.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
F16B3'CL, ANTI-DEXTRAN B512
HDEX4, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
4.3.6F8'CL, ANTI-ALPHA 1,6 DEXTRAN
DN3'CL, ANTI-MCPS
1C10'CL, ANTI-DIGOXIN
SC4'CL, ANTI-MCPS
SC12'CL, ANTI-MCPS
9.14.7'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
45.21.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX9, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
59.1G2.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
42.7C.11.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
19.22.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
DN11'CL, ANTI-MCPS
26-10VH'CL, ANTI-DIGOXIN
DN8'CL, ANTI-MCPS
4.3F1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
scFv(digoxin)'CL, ANTI-DIGOXIN
42.2A.7.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
DN4'CL, ANTI-MCPS
IdB5.7'CL, ANTIIDIOTYPE TO ANTI-ALPHA 1,6 DEXTRAN 45.21.1
5.54.4.24.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
DN12'CL, ANTI-MCPS
36.1.2D'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX8, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
SC5'CL, ANTI-MCPS
19.1.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
45-20, ANTI-DIGOXIN
MOPC104E, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN
4.1.3C4'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
CHIMPANZEE CH4-14'CL, ANTI-DIGOXIN HYBRIDOMA
SR2E7'CL, ANTI-DIGOXIN
DN9'CL, ANTI-MCPS
HY GAL8, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
37.1E5.2'CL, ANTI-ALPHA 1,6 DEXTRAN
HDEX24, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX25, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX3, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
10.2.8a'CL, ANTI-ALPHA 1,6 DEXTRAN
KL.SJA83.12'CL, ANTI-DEXTRAN B1355 HYBRIDOMA
HDEX10, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
36.5.7B'CL, ANTI-ALPHA 1,6 DEXTRAN
HDEX11, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
26.4.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX12, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
42.5D4.2a'CL, ANTI-ALPHA 1,6 DEXTRAN
HDEX14, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
37.1.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
F3A11'CL, ANTI-DEXTRAN B512
42.7B3.2'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
SC13'CL, ANTI-MCPS
40-160, ANTI-DIGOXIN
4.2.6D12'CL, ANTI-ALPHA 1,6 DEXTRAN
F4H2'CL, ANTI-DEXTRAN B512
16.4.12E'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
37.1E5.2a'CL, ANTI-ALPHA 1,6 DEXTRAN
DN6'CL, ANTI-MCPS
DN1'CL, ANTI-MCPS
LB4'CL, ANTI-DIGOXIN
scFv(DIGOXIN)'CL, ANTI-DIGOXIN
14.6b.1'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX2, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
HDEX6, ANTI-ALPHA 1,3 ALPHA 1,6 DEXTRAN HYBRIDOMA
F3D2'CL, ANTI-DEXTRAN B512
35.8.2H'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
HY GAL6, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
SR1C7'CL, ANTI-DIGOXIN
W3129'CL, ANTI-ALPHA 1,6 DEXTRAN
LL2'CL, ANTI-DIGOXIN
3H-3H'CL, ANTI-DIGOXIN
F12E6'CL, ANTI-DEXTRAN B512
DN10'CL, ANTI-MCPS
40-40, ANTI-DIGOXIN
DN5'CL, ANTI-MCPS
F12B2'CL, ANTI-DEXTRAN B512
3.4.1G6'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
28.4.10A'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
10.2.8'CL, ANTI-ALPHA 1,6 DEXTRAN
9.4.5'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
4.3.6.F8a'CL, ANTI-ALPHA 1,6 DEXTRAN
66.4A10'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
K9-338, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
7S34.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE, ANTI-BETA-1,3-N-ACETYL-D-GLUCOSAMINE
66.5A3'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
50S10.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
B1Fv'CL, ANTI-LEWIS(GAMMA)-RELATED CARBOHYDRATE ANTIGEN ABUNDANT ON VARIOUS CARCINOMAS
K30-267, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
mAb10.2.3'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
60.1B5'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
K49-501, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
VK-25-39'CL, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
mAb10.2.5'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
VK-25-47'CL, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
mAb3.B6'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
B3(Fv)'CL, ANTI-CARBOHYDRATE ANTIGEN IN THE LEY FAMILY
65.1B3'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
4153-I, ANTI-STREPTOCOCCAL GROUP C CARBOHYDRATE
K27-489, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
mAb1.H9'CL, ANTI-N-ACETYL-BETA-D-GLUCOSAMINE (THE DOMINANT EPITOPE OF THE GROUP A STREPTOCOCCAL CARBOHYDRATE) & ANTI-HUMAN CARDIAC MYOSIN
L6' 'CL, ANTIBODY TO A CARBOHYDRATE ANTIGEN ON SURFACE OF HUMAN CARCINOMAS OF LUNG, BREAST AND OVARY
68.2D8'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
K16-167, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
ABL364'CL, ANTI-LEWIS Y CARBOHYDRATE ANTIGEN (LE Y)
17S29.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
K4820, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
K29-213, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
4135, ANTI-STREPTOCOCCAL GROUP C CARBOHYDRATE
B5Fv'CL, ANTI-LEWIS(GAMMA)-RELATED CARBOHYDRATE ANTIGEN ABUNDANT ON VARIOUS CARCINOMAS
K9-335, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
PB17IV'CL, ANTI-STREPTOCOCCUS GROUP A CARBOHYDRATE WITH SPECIFICITY FOR N-ACETYL GLUCOSAMINE
68.2C4'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
HUMANIZED ABL364 VARIANT K, ANTI-LEWIS Y CARBOHYDRATE ANTIGEN (LE Y)
K87-529, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
22S25.1, ANTI-STREPTOCOCCAL GROUP A CARBOHYDRATE HYBRIDOMA
68.3D3'CL, ANTI-GROUP A STREPTOCOCCAL CARBOHYDRATE HYBRIDOMA
K27-306, ANTI-STREPTOCOCCAL GROUP A VARIANT CARBOHYDRATE
HY GAL3, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
HY GAL2, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
TEPC601, ANTI-BETA 1,6 D-GALACTAN
HY GAL12, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
HY GAL1, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
SAPC10, ANTI-BETA 1,6 D-GALACTAN
TEPC191, ANTI-BETA 1,6 D-GALACTAN
WEA, ANTI-3,4-PYRUVYLATED GALACTOSE MONOCLONAL
XRPC24, ANTI-BETA 1,6 D-GALACTAN
HY GAL10, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
G9'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC (ALPHA-GALACTOSYL) EPITOPE
P19'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC (ALPHA-GALACTOSYL) EPITOPE
HY GAL7, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
HY GAL11, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
HY GAL4, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
1/1'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=7X10EXP7)
40-150 A2.4 P.10'CL, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=4.4X10EXP8)
UPC61, ANTI-BETA 2,1 FRUCTOSAN
40-60, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=6.7X10EXP9)
1/11'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
LD-3'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
40-100, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=7.1X10EXP9)
9/24'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=7X10EXP7)
32'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
M6'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBDIROMA
HY GAL9, ANTI-BETA 1,6 D-GALACTAN HYBRIDOMA
4/F'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
T957, ANTI-BETA 2,1 FRUCTOSAN
ABPC4, ANTI-BETA 2,1 FRUCTOSAN
40-150'CL, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=5.4X10EXP9)
PMN6'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
PMN29'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBDIROMA
UPC10'CL, ANTI-BETA 2,6 FRUCTOSAN
PM81'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
40-90, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=5.4X10EXP9)
10/12'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=1.0X10EXP8)
19/3'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R
5/8'CL, ANTI-GAL ALPHA 1-3 GAL BETA 1-4 GLCNAC-R (BINDING CONSTANT=6X10EXP6)
26-10, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=3.1X10EXP9)
40-20, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=5.9X10EXP9)
W3082, ANTI-BETA 2,1 FRUCTOSAN
ABE48'CL, ANTI-BETA 2,6 FRUCTOSAN
40-150 A2.4'CL, ANTI-DIGOXIN HYBRIDOMA(BINDING CONSTANT=9X10EXP6)
AMPC1, ANTI-BETA 2,1 FRUCTOSAN
M5'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBRIDOMA
M3'CL, ANTI-3-FUCOSYLLACTOSAMINE HYBDIROMA
28.4.10A'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
10.2.8'CL, ANTI-ALPHA 1,6 DEXTRAN
9.4.5'CL, ANTI-ALPHA 1,6 DEXTRAN HYBRIDOMA
4.3.6.F8a'CL, ANTI-ALPHA 1,6 DEXTRAN